- Home
- AMBC vs RZLT Comparison
AMBC vs RZLT Comparison
Compare AMBC & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBC
- RZLT
- Stock Information
- Founded
- AMBC 1971
- RZLT 2010
- Country
- AMBC United States
- RZLT United States
- Employees
- AMBC N/A
- RZLT N/A
- Industry
- AMBC Property-Casualty Insurers
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- AMBC Finance
- RZLT Health Care
- Exchange
- AMBC Nasdaq
- RZLT Nasdaq
- Market Cap
- AMBC 411.3M
- RZLT 361.3M
- IPO Year
- AMBC 1991
- RZLT N/A
- Fundamental
- Price
- AMBC $8.28
- RZLT $6.13
- Analyst Decision
- AMBC Strong Buy
- RZLT Strong Buy
- Analyst Count
- AMBC 2
- RZLT 6
- Target Price
- AMBC $12.50
- RZLT $12.00
- AVG Volume (30 Days)
- AMBC 1.1M
- RZLT 1.1M
- Earning Date
- AMBC 08-07-2025
- RZLT 09-18-2025
- Dividend Yield
- AMBC N/A
- RZLT N/A
- EPS Growth
- AMBC N/A
- RZLT N/A
- EPS
- AMBC N/A
- RZLT N/A
- Revenue
- AMBC $253,912,000.00
- RZLT N/A
- Revenue This Year
- AMBC N/A
- RZLT N/A
- Revenue Next Year
- AMBC $17.41
- RZLT N/A
- P/E Ratio
- AMBC N/A
- RZLT N/A
- Revenue Growth
- AMBC 125.08
- RZLT N/A
- 52 Week Low
- AMBC $5.99
- RZLT $2.22
- 52 Week High
- AMBC $13.64
- RZLT $6.65
- Technical
- Relative Strength Index (RSI)
- AMBC 60.51
- RZLT 67.49
- Support Level
- AMBC $8.52
- RZLT $5.22
- Resistance Level
- AMBC $8.87
- RZLT $6.65
- Average True Range (ATR)
- AMBC 0.40
- RZLT 0.33
- MACD
- AMBC 0.03
- RZLT 0.03
- Stochastic Oscillator
- AMBC 69.61
- RZLT 60.32
About AMBC Ambac Financial Group Inc.
Ambac Financial Group Inc is a financial services holding company. It operates in two principal businesses segments: Insurance Distribution and Specialty Property & Casualty Insurance. Insurance Distribution segment includes Managing General Agents, Underwriters and other appointed and delegated underwriting businesses (collectively MGAs or MGA/Us), an insurance broker, and other distribution and underwriting businesses. Specialty Property & Casualty Insurance includes five carriers (collectively, Everspan). Key revenue is generated from Insurance Distribution.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.